Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Adipocytes induce melanoma plasticity by sensitizing cells to TGFb

ABSTRACT: Adipocytes induce melanoma plasticity by sensitizing cells to TGFb

PROVIDER: PRJNA489361 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Adipocytes induce melanoma plasticity by sensitizing cells to TGFb

Project description:Transcriptome analysis of: 1- WM1716 melanoma cell line transfected with scrambled control or with miR-211. 2- WM3682 cell line mono-cultured or co-cultured with adipocytes.

2021-09-01 | GSE119478 | GEO

Naringenin and beta-carotene induce energy expenditure and insulin sensitizing genes in human white adipocytes

Project description:Naringenin and beta-carotene induce energy expenditure and insulin sensitizing genes in human white adipocytes

| PRJNA925566 | ENA

Naringenin and beta-carotene induce energy expenditure and insulin sensitizing genes in human white adipocytes

Project description:Changes in expressed genes will be sequenced for regulatory pathway analysis in human adipocytes

2023-05-10 | GSE223313 | GEO

PPARγ agonists induce biased signaling in human adipocytes

Project description:PPARγ agonists induce biased signaling in human adipocytes

| PRJNA1105894 | ENA

RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids

Project description:We recently isolated and identified (7E)-9-oxohexadec-7-enoic acid (1) and (10E)-9-oxohexadec-10-enoic acid (2) from the marine algae Chaetoceros karianus. Synthesis and biological characterization show that these are PPARα/γ dual agonists. Herein we report the gene expression data from human SGBS pre-adipocytes, stimulated to differentiate with 1, 2 or the classical PPARγ agonist rosiglitazone. The transcriptome analysis shows that both compounds induce anti-diabetic gene programs in adipocytes by upregulating insulin-sensitizing adipokines and repressing pro-inflammatory cytokines.

2018-06-26 | GSE115827 | GEO

DMD-TGFb-SETDB1

Project description:DMD-TGFb-SETDB1

| PRJEB63300 | ENA

PPARγ agonists induce biased signaling in human adipocytes

Project description:Biased signaling and ligand bias, often referred to as functional selectivity or selective nuclear receptor modulation, have been reported for many nuclear receptor partial agonists over the past 20 years. However, whether differences in nuclear receptor signaling produced by partial and full agonists results from less intense partial agonist modulation, off-target effects, or biased signaling remains unclear. To determine whether biased signaling can occur through nuclear receptors we compare the transcriptional effects of two full agonists (which also favor different coactivator peptides) in human adipocytes. We also test the signaling effects of a partial agonist relative to full agonists. Furthermore, whether biased coactivator peptide recruitment translates to biased signaling in cells has not been determined. In a step towards this goal, we show that these same full agonists induce biased recruitment of 100-300 residue regions of coactivators containing all their nuclear receptor binding motifs. Together these data support the idea that nuclear receptor agonists can induce biased signaling through differences in coactivator recruitment.

2025-10-26 | GSE266107 | GEO

SETDB1-Dependent Modulation of the TGFb-induced Secretome in Duchenne Muscular Dystrophy: The Role of EMILIN1

Project description:Duchenne Muscular Dystrophy (DMD) is a severe X-linked muscle-wasting disorder characterized by chronic inflammation, progressive fibrosis, and impaired muscle regeneration. The TGFb pathway is overactivated in DMD and it sustains the accumulation of extracellular matrix (ECM), contributing to fibrosis. Our previous results showed that SETDB1 regulates the expression of TGFb-dependent secreted factors impacting fibrosis and myogenic differentiation. In particular, the conditioned medium (CM) of TGFb-treated myotubes impairs myoblasts differentiation and increase fibrosis. In this study, we performed a thorough proteomic analysis of the secretome from DMD myotubes under TGFb stimulation, with or without SETDB1 LOF, to identify secreted factors involved in the dysregulated regenerative environment of DMD. We found that SETDB1 modulates the TGFb-induced secretome, particularly by regulating ECM-related proteins. Among these, we identified EMILIN1, an ECM glycoprotein not previously studied in skeletal muscle. EMILIN1 is upregulated by TGFb reduced upon SETDB1 depletion and more abundant in DMD myotubes. Functional analyses revealed that EMILIN1 LOF impairs late myogenic differentiation and reduces the expression of the fibrotic marker SERPINE1. These findings highlight EMILIN1 as a secreted regulator of myogenesis and fibrosis, and support the role of SETDB1 in regulating the TGFb-dependent secretome in DMD. This study provides new insights into the molecular players contributing to the fibrotic and regenerative defects in DMD, offering potential therapeutic targets for disease intervention.

2026-08-24 | PXD068544 | Pride

Tgfb in AT1 cells

Project description:Tgfb in AT1 cells

| PRJNA958167 | ENA

Transcriptomics of Tgfb signaling

Project description:Transcriptomics of Tgfb signaling

| PRJNA991708 | ENA